Similar Articles
1051 Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis
1052 Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
1053 Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
1054 Hepatitis D and hepatocellular carcinoma
1055 Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
1056 Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
1057 Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma
1058 Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients
1059 Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma
1060 Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA